<DOC>
	<DOCNO>NCT02434445</DOCNO>
	<brief_summary>This study investigate use novel plasma urinary biomarkers predicte development hepatorenal syndrome patient advanced cirrhosis . The biomarkers investigate include plasma cystatin C , plasma NGAL , plasma NAG , plasma IL-18 , plasma ADMA , plasma BTP , urinary KIM-1 urinary LFABP . These biomarkers check advanced cirrhotic patient develop hepatorenal syndrome compare two group . These biomarkers also correlate occurence hepatorenal syndrome .</brief_summary>
	<brief_title>Use Novel Plasma Urinary Biomarkers Predict Development Hepatorenal Syndrome Cirrhotic Patients</brief_title>
	<detailed_description>This study investigate use novel plasma urinary biomarkers predicte development hepatorenal syndrome patient advanced cirrhosis . The biomarkers test include plasma cystatin C , plasma NGAL , plasma NAG , plasma IL-18 , plasma ADMA , plasma BTP , urinary KIM-1 urinary LFABP . These biomarkers check advanced cirrhotic patient develop hepatorenal syndrome compare two group . These biomarkers also correlate occurence hepatorenal syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hepatorenal Syndrome</mesh_term>
	<criteria>Patients advanced cirrhosis ( Child 's B C ) refer liver transplantation Willing give inform consent Patients coexist renal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>